Chris@CNW, Author at CannabisNewsWire

TuesdayFeb 28, 2023 4:20 am

420 with CNW — Canadian Industry Groups Want Federal Fees on Marijuana Reduced to Relieve Operator Burden

A group of Canadian cannabis executives has shined a light on what it says are unsustainable federal fees on the nascent industry. The executives are asking the federal government to offer the industry some relief from the federal tax fees amid widespread financial losses and increasing job losses. During a news conference last week, the executives argued that job losses would continue to pile up if the federal government did not make any meaningful reform. Even though cannabis is legal across dozens of states in the United States and in Canada as well, industry players have been forced to contend…

MondayFeb 27, 2023 4:20 pm

420 with CNW — Twitter’s Decision Gives US Marijuana Companies Advertising Boost

Industry insiders say that Twitter's recent policy change allowing state-legal marijuana businesses to advertise and market on the platform is a positive development for the sector and may prompt other digital advertising platforms to reconsider their bans on cannabis promotion. Twitter is simultaneously enhancing its entry into American marijuana advertising through a promotional incentive for the sector. However, there are still some uncertainties regarding the specifics of what Twitter's new marijuana advertising policy allows and prohibits. In the opinion of Lisa Buffo, CEO and founder of the Cannabis Marketing Association, the move is a definite sign that marijuana is becoming…

MondayFeb 27, 2023 10:30 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Additional HYPER-H21-4 Study Findings Offer Better Understanding of the Anti-Hypertensive Effects of DehydraTECH-CBD

Dosing for Lexaria’s ambitious and most comprehensive clinical study, HYPER-H21-4, was successfully completed in July 2022, with newly analyzed results now emerging Its latest findings bring the company closer to its upcoming FDA Phase 1b study while also explaining the patented DehydraTECH-(TM)-processed CBD interaction with the sympatho-chromaffin system via catestatin modulation Lexaria’s management is optimistic that DehyraTECH-CBD and its effectiveness in modulating catestatin levels could become a significant value enhancer should it eventually enter the marketplace as an approved hypertension treatment Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, kicked off its human clinical study, HYPER-H21-1 in…

MondayFeb 27, 2023 4:20 am

420 with CNW — Wisconsin Governor Releases Budget Request That Features Cannabis Legalization

Wisconsin Governor Tony Evers (D) recently unveiled the state's biennial budget proposal, which once more includes language supporting the legalization of both medical and recreational cannabis. The governor made it known that he intended to include the adult-use proposal in his request, despite a top Republican lawmaker's warning that doing so might jeopardize talks on more moderate medical marijuana legislation. He also stated that he would not be persuaded to drop the proposal owing to the fact that he promised to work for comprehensive legalization during the campaign and a majority of state voters support the change in law. However,…

FridayFeb 24, 2023 4:20 pm

420 with CNW — President Biden Issues Executive Order on Cannabis Equity

Reform activists have long concluded that the drug war of the 1980s and 1990s is an unmitigated failure. Although the war on drugs was ostensibly launched to cut financial outflows to criminal organizations and address drug addiction in the United States, it has resulted in the incarceration of significant numbers of people on minor drug charges, decimated families in Black and Brown communities and contributed to already entrenched racial disparities. Now that cannabis drug reform is sweeping across the country, most states have included social justice provisions in their cannabis laws to try and alleviate the disproportionate damage caused by…

FridayFeb 24, 2023 4:20 am

420 with CNW — NJ Supreme Court Clears Confusion on Cannabis Expungement Law

The Supreme Court of New Jersey recently ruled that first-time offenders who avoided conviction for minor drug offenses by enrolling in a diversionary program before legislators in the state decriminalized cannabis two years ago could still be enrolled to another program for any new offenses. The unanimous ruling was an effort to analyze the intent of the Cannabis Regulatory, Enforcement Assistance and Marketplace Modernization Act. While this law decriminalized the simple possession of marijuana in the state of New Jersey and directed that previous cannabis convictions be expunged automatically from an individual’s criminal record, it did not look into how…

ThursdayFeb 23, 2023 4:20 pm

420 with CNW — Schumer Meets GOP Senators Over Cannabis Legislation in New Congress

In January, Senate Majority Leader Chuck Schumer (D-NY) convened a second meeting to discuss cannabis legislation for the 118th Congress. This time, he invited a group of Republican senators to strategize the next steps for drafting a bill that could pass. The first meet-up with Democratic colleagues occurred at the beginning of February. In the recent meeting, the GOP leaders present included Senators Dan Sullivan (R-AK), Rand Paul (R-KY), and Steve Daines (R-MT). The aim of these meetings is to establish a mechanism through which legislators can reach a bipartisan agreement on marijuana reform bill goals in the current Republican-controlled…

ThursdayFeb 23, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking Forward to 2023 Goals for Patented DehydraTECH(TM) Technology

Lexaria’s 2022 R&D efforts saw high levels of success, establishing the company as one of the world’s leaders in the investigation of CBD for controlling human blood pressure and, separately, demonstrating performance enhancements compared to one of the world's leading anti-seizure medications During Q1 2023, Lexaria expects to provide additional results from its hypertension study HYPER-H21-4; complete dosing in the company’s animal dementia and diabetes studies; complete dosing in the human nicotine study NIC-H21-1; and submit and publish additional results in research journals Lexaria’s DehydraTECH technology currently has 28 granted patents, with many more pending patents in countries worldwide Lexaria…

ThursdayFeb 23, 2023 4:20 am

420 with CNW — Questions Arise on Delays to Implement Presidential Cannabis Pardons

All American citizens who suffer from the burden associated with federal cannabis-related convictions on their prior record were meant to be granted unconditional pardons, per the president’s directive in October. According to the president, thousands of Americans have existing federal records for cannabis use and risk being denied work, residence or educational prospects. Never in history has a president-elect publicly acknowledged the shortcomings of America's almost century-long experiment with marijuana restriction, a measure that most states have already abandoned. Currently, about two-thirds of citizens believe it has to be done away with. Additionally, no president has ever shown commitment to…

WednesdayFeb 22, 2023 4:20 pm

420 with CNW — California Mulls Allowing Marijuana Cafes to Boost the Industry

Earlier this month, Assemblymember Matt Haney introduced a measure to legalize the sale of nonalcoholic beverages and food at marijuana lounges and retailers in the state of California. California was the first state in the country to legalize the use of medical cannabis in 1996, following the approval of Proposition 215. Two decades later, the state legalized the recreational sale and distribution of the drug following the passage of Proposition 64. Haney stated that while some cafes did permit the consumption of marijuana, the no-drinking and no-eating rule made them less than ideal. Under the proposed measure, called Assembly Bill…